Élise Deluche

Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial

Fernanda Mosele, Élise Deluche, Amélie Lusque et al. · Nature Medicine · 2023 · 370 citations · Full text

Medicine, Oncology, Pharmacology +17

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 192 citations

Medicine, Gynecology, Oncology +17

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Ronan Flippot, Cécile Dalban, Brigitte Laguerre et al. · Journal of Clinical Oncology · 2019 · 163 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Impact of body composition on outcome in patients with early breast cancer

Élise Deluche, Sophie Léobon, Jean Claude Desport et al. · Supportive Care in Cancer · 2017 · 156 citations · Full text

Medicine, Oncology, Radiology +15

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

Thomas Grinda, Alison Antoine, William Jacot et al. · ESMO Open · 2021 · 134 citations · Full text

Medicine, Oncology, Breast Oncology +12